Keranova’s PhotoEmulsification technique shows promising results
Click Here to Manage Email Alerts
Keranova reported positive results for FemtoMatrix, its robotic laser technology used for PhotoEmulsification in cataract surgery.
“These outstanding results, achieved after 6 years of hard work, will soon allow Keranova to offer PhotoEmulsification technology to surgeons,” Fabrice Romano, Keranova founder and CEO, said in a press release. “This will be the third generation of cataract surgery technology, after manual extracapsular and phacoemulsification.”
Source: Adobe Stock.
In a randomized, comparative, multicenter pivotal study, 54 participants underwent cataract surgery with PhotoEmulsification in one eye and traditional phacoemulsification in the other eye as a control. In the majority of cases, FemtoMatrix reduced or eliminated the use of ultrasound.
In a subpopulation of 20 participants with a cataract grade of 3 or less, the reduction in effective phacoemulsification time was 100% compared with an average of 20% to 30% in comparative meta-analyses, according to the release.
In two more studies comprising 35 participants with a cataract grade higher than 3, approximately 72% of surgeries did not require ultrasound. Ten participants who received ultrasound had an average effective phacoemulsification time of 2.3 seconds.
“The results are extremely promising, as the FemtoMatrix device has proven to be safe to perform phaco-free laser cataract surgery in less than 8 minutes in one operating room, something which is impossible to do with current techniques,” Damien Gatinel, MD, PhD, Keranova scientific advisory board member, said in the release.
The company, which is applying for a CE mark for the technology, said full results of the clinical regulatory studies will be published this year.
Read more about
Click Here to Manage Email Alerts